Nombre del producto |
5-[(2S)-2-hidroxi-2-(3,4,5-trimetoxifenil)etil]-2-metoxifenol |
Sinónimos |
; 5-[(2S)-2-hidroxi-2-(3,4,5-trimetoxifenil)etil]-2-metoxifenol; bencenoetanol, 3-hidroxi-4-metoxi-alfa-(3,4,5-trimetoxifenil)-, (alfaS)-; 5-[(2R)-2-hidroxi-2-(3,4,5-trimetoxifenil)etil]-2-metoxifenol;; (-)-combretastatina; (R)-3-hidroxi-4-metoxi-a-(3,4,5-trimetoxifenil)bencenoetanol; 5-[(2R)-2-hidroxi-2-(3,4,5-trimetoxifenil)etil]-2-metoxifenol; Benzeneetanol, 3-hidroxi-4-metoxi-alfa-(3,4,5-trimetoxifenil)-, (R)-; 5-[2-hidroxi-2-(3,4,5-trimetoxifenil)etil]-2-metoxifenol;; 3-hidroxi-4-metoxi-alfa-(3,4,5-trimetoxifenil)bencenoetanol; bencenoetanol, 3-hidroxi-4-metoxi-alfa-(3,4,5-trimetoxifenil)- |
Nombre en inglés |
5-[(2S)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; 5-[(2S)-2-Hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)-, (alphaS)-; 5-[(2R)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; ; (-)-Combretastatin; (R)-3-Hydroxy-4-methoxy-a-(3,4,5-trimethoxyphenyl)benzeneethanol; 5-[(2R)-2-Hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; Benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)-, (R)-; 5-[2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol; ; 3-Hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)benzeneethanol; benzeneethanol, 3-hydroxy-4-methoxy-alpha-(3,4,5-trimethoxyphenyl)- |
Fórmula molecular |
C18H22O6 |
Peso Molecular |
334.3637 |
InChI |
InChI=1/C18H22O6/c1-21-15-6-5-11(8-14(15)20)7-13(19)12-9-16(22-2)18(24-4)17(10-12)23-3/h5-6,8-10,13,19-20H,7H2,1-4H3/t13-/m0/s1 |
Número de registro CAS |
82855-09-2 |
Estructura Molecular |
|
Densidad |
1.213g/cm3 |
Punto de ebullición |
485.3°C at 760 mmHg |
Índice de refracción |
1.569 |
Punto de inflamación |
247.3°C |
Presión de vapor |
3.14E-10mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|